Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone effects on endothelial function and microcirculation in hypogonadal men with type 2 diabetes
2010-020018-27Phase 4Terminated
- Sponsor
- Tameside and Glossop Integrated Care NHS Foundation Trust
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of testosterone undecanoate and vardenafil in Hypoandrogenism (TD) and erectile dysfunction (ED) (2 arms), sponsored by Tameside and Glossop Integrated Care NHS Foundation Trust. Primary endpoint: Improvement in endothelial function. Started Mar 2012; status: terminated.
02
Drugs
testosterone undecanoatevardenafil
03
Conditions
Hypoandrogenism (TD)erectile dysfunction (ED)
Beyond the preview
Go deeper on 2010-020018-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020018-27.